Here is a PDF
copy of my professional
profile at Beijing East IP.
Liaoteng Wang, Ph.D., J.D.
Attorney at Law
Licensed in the States of California and Wisconsin
Admitted to USPTO, CAND, WIWD, and CAFC; CIPP/US
Licensed California Real Estate Broker
Email:
LIAOTENG.WANG@beijingeastip.com
Select
Representations:
• Defended SMIC against TSMC (represented by Keker & Van Nest) in a bet-the-company billion-dollar trade secrets/breach of contract case involving semiconductor device fabrication technologies: drafted document requests, interrogatories, and discovery responses; conducted document review; assisted offensive and defensive depositions; worked on expert declarations on ion implantation and design rules; defeated Motion for Preliminary Injunction by TSMC.
• Defended Affymetrix against MIT and E8 Pharmaceuticals (represented by the Blackberry Lawsuit Lawyers at Wiley Rein) in a patent infringement case involving hundreds of millions of dollars of damages claims: served as the lead associate and managed all aspects of the case from the initial disclosure to the close of fact discovery; formulated claim construction and case strategies; interviewed Nobel Laureate Kary Mullis; prepared the partners for the depositions of Professor David Housman and Professor Eric Lander; won Motion to Dismiss at the District Court and judgment of non-infringement at the Federal Circuit.
• Represented UTStarcom in an FCPA investigation initiated by the U.S. Department of Justice.
• Avoided an AAA arbitration and resolved a licensing dispute with Eastman Kodak Company involving millions of dollars of claims for overpaid royalties; recovered over half a million dollars in unpaid royalties from a top PC and device manufacturer through AAA
arbitration without using outside counsel.
• Prosecuted and managed U.S. and foreign patent and trademark applications; managed a portfolio of hundreds of patents, patent applications, trademarks, and trademark applications.
• Provided legal counseling to hundreds of researchers in dozens of high-tech labs at the U.S. R&D Center of Samsung Electronics conducting cutting-edge research and development of products and services such as wearables, digital health, mobile platforms and applications, mobile security, big data intelligence, cloud computing, media solutions, smart TVs, set-top box, audio, IoT, user experience, wireless communications, and medical devices, on issues such as intellectual property, open source, and privacy.
• Drafted and negotiated agreements including content licenses, consulting agreements, sponsored research agreements, material transfer agreements, business associate agreements, and collaboration agreements with universities such as MIT and Harvard and hospitals such as Kaiser and MGH.
• Provided legal support and overall project management for the US$250 million purchase of the Mountain View campus by Samsung from a San Francisco Bay Area developer in
2015; handled other commercial real estate transactions totaling over
US$300 Million; reviewed and negotiated purchase and sale agreements,
leases, and other real estate related agreements.
• Negotiated and closed multi-million dollar services agreements and software licenses with Dell, Motorola, Nokia, Qualcomm, and Broadcom, respectively.
• Experimented with a corporate inversion from California to Cayman Islands through a reverse triangular merger to enable potential future listing on Hong Kong Stock Exchange and Taiwan Stock Exchange; closed US$20 million Series C Financing participated by Intel Capital and Tudor Ventures in preparation for an IPO; assisted in the establishment of a double Irish structure to lower corporate tax.
• Successfully petitioned and obtained employment-based green cards.
Select
Publications and Speaking Engagements:
Liaoteng Wang, “To Disclose, or Not to Disclose:
the Law after Therasense en banc.”
Slideshare,
June 23, 2011.
Liaoteng Wang, “Vive la Différence: the Written
Description Requirement Is Not Coextensive with the Enablement
Requirement.” IP
Law360, January 26, 2010.
Wang L, Eckmann CR, Kadyk LC, Wickens M, Kimble J,
“A regulatory cytoplasmic poly(A) polymerase in C. elegans.” Nature,
2002, 419(6904):312-6.
|